2012: The year in dementia

The Lancet Neurology

Volumn 12, Issue 1, 2013, Pages 4-6

  Gandy, Sam ^a   DeKosky, Steven T ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BAPINEUZUMAB; SOLANEZUMAB;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; DEMENTIA; HUMAN; NOTE; PRIORITY JOURNAL; TRAUMATIC BRAIN INJURY;

ANIMALS; CLINICAL TRIALS AS TOPIC; DEMENTIA; HUMANS; MUTATION; TIME FACTORS;

EID: 84870848519     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70284-3     Document Type: Note

References (12)

1. Jonsson T, Atwal JK, Steinberg S, et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 2012, 488:96-99.
2. Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012, 367:795-804. Dominantly Inherited Alzheimer Network.
3. Reiman EM, Quiroz YT, Fleisher AS, et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol 2012, 11:1048-1056.
4. Blennow K, Zetterberg H, Rinne JO, et al. Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. Arch Neurol 2012, 69:1002-1010. AAB-001 201/202 Investigators.
5. Farlow M, Arnold SE, van Dyck CH, et al. Safety and biomarker effects of solanezumab in patients with Alzheimer's disease. Alzheimers Dement 2012, 8:261-271.
6. Omalu B, Hammers JL, Bailes J, et al. Chronic traumatic encephalopathy in an Iraqi war veteran with posttraumatic stress disorder who committed suicide. Neurosurg Focus 2011, 31:E3.
7. Gandy S, Dekosky ST APOE e{open}4 status and traumatic brain injury on the gridiron or the battlefield. Sci Transl Med 2012, 4:134ed4.
8. Jonsson T, Stefansson H, Ph DSS, et al. Variant of TREM2 Associated with the Risk of Alzheimer's Disease. N Engl J Med 2012, published online Nov 14. 10.1056/NEJMoa1211103.
9. vom Berg J, Prokop S, Miller KR, et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nature Med 2012, published online Nov 25. 10.1038/nm.2965.
10. de Calignon A, Polydoro M, Suárez-Calvet M, et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012, 73:685-697.
11. Liu L, Drouet V, Wu JW, et al. Trans-synaptic spread of tau pathology in vivo. PLoS One 2012, 7:e31302.
12. Luk KC, Kehm VM, Zhang B, O'Brien P, Trojanowski JQ, Lee VM Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J Exp Med 2012, 209:975-986.